University of Missouri-Columbia Hematology and Medical Oncology

Topics

• Hematopoietic Stem Cell Transplantation 58
• Multiple Myeloma Research and Treatments 57
• Amyloidosis: Diagnosis, Treatment, Outcomes 25
• CAR-T cell therapy research 24
• Lymphoma Diagnosis and Treatment 23
• Acute Myeloid Leukemia Research 17
• Chronic Lymphocytic Leukemia Research 16
• Chronic Myeloid Leukemia Treatments 10
• Glioma Diagnosis and Treatment 9
• Electrolyte and hormonal disorders 7
• Autoimmune and Inflammatory Disorders Research 6
• Blood Coagulation and Thrombosis Mechanisms 6

Most cited

1. Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 84 citations · Bilawal Ahmed

2. Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab.

   The New England journal of medicine · 2026 · 33 citations · Shahzad Raza

3. Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study.

   The Lancet. Oncology · 2022 · 223 citations · Gerhard Hildebrandt

4. Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis.

   Blood · 2021 · 170 citations · Maxwell Krem

5. Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 48 citations · Shahzad Raza

6. Safety and Efficacy of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience.

   Transplantation and cellular therapy · 2024 · 83 citations ·